Loading...
•
Dec 31, 2020
NeoGenomics Q4 2020 Earnings Report
NeoGenomics reported an 18% revenue increase, reaching $126 million.
Key Takeaways
NeoGenomics, Inc. reported an 18% increase in consolidated revenue for the fourth quarter of 2020, reaching $126 million. Clinical Services revenue increased by 14% to $107 million, while Pharma Services revenue grew by 43% to $19 million. Net income for the quarter was $15 million, compared to $6 million in the same period of 2019.
Consolidated revenue increased 18% to $126 million.
Clinical Services revenue increased 14% to $107 million.
Pharma Services revenue increased 43% to $19 million.
Pharma Services backlog increased 60% to $209 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...